ODAT

January 13, 2016

The Translational Product Development Fund (TPDF) program has released an RFA for its third cycle of funding to support health research projects that are intended to lead to the development of a novel therapeutic, device, diagnostic, or IT product, and have the potential to be commercialized through the formation of a start-up company or license to an established commercial entity. 

January 6, 2016

Valerie PierreCTSI is providing funding and support to Associate Professor Dr. Valerie Pierre, who envisions a cheap, easy-to-use diagnostic tool that could provide a faster way to diagnose bacterial infections.

Initial funding, guidance, and support from CTSI proved such a tool could be feasible, and a subsequent award that’s co-administered by CTSI is now enabling her to develop a prototype.

January 6, 2016

In July 2014, CTSI’s Office of Discovery and Translation (ODAT) awarded funding and support through its Translational Grant Program to develop a non-invasive lung pacing device that is intended to reduce the length of time patients must be supported with ventilators. The technology was licensed to a University of Minnesota med-tech start-up company that recently acquired $1.9 million in equity financing.

December 3, 2015

Four research projects have been selected to receive Translational Product Development Fund (TPDF) awards, initially providing up to $50,000 in direct expenses to develop novel therapeutic compounds, devices, diagnostics, or IT products that have the potential to be commercialized. Successful projects will be eligible for additional funding through this program.

December 3, 2015

CTSI and the Pediatric Device Innovation Consortium (PDIC) have announced the 2015 awardees of its Pediatric Medical Device Translational Grant Program that supports the development of pediatric medical devices with the ultimate goal of improving pediatric patient outcomes and quality of life through technology-driven medical solutions. 

April 28, 2015

Five research projects were awarded through the Translational Product Development Fund (TPDF) program, a joint initiative between CTSI and the Mayo Clinic Center for Clinical and Translational Science (CCaTS), in conjunction with the Minnesota Partnership for Biotechnology and Medical Genomics (MNP). The program supports health research projects that intend to develop a novel therapeutic compound, device, diagnostic, or IT product, and have the potential to be commercialized.

November 17, 2014

Investigators from the University of Minnesota and the Mayo Clinic have a new opportunity to advance their research, thanks to the launch of the Translational Product Development Fund (TPDF).

August 5, 2014

The Clinical and Translational Science Institute (CTSI) and Pediatric Device Innovation Consortium (PDIC) have announced the inaugural awardees of the Pediatric Medical Device Translational Grant Program.

July 11, 2014

The Clinical and Translational Science Institute (CTSI) has awarded funds to support 15 research projects that will be conducted by U of M investigators and their collaborators. Funding from three CTSI grant programs will support a wide range of projects, from early-stage, translational research to clinical research to community-engaged research. Congratulations to our newest awardees!

June 4, 2014

Lab equipmentWe've all read about exciting health breakthroughs, but how do these discoveries make their way into new treatments, therapies, and tools? In the April issue of Minnesota Health Care News, two members of our leadership team talk about how research is conducted, and detail the Clinical and Translational Science Institute's approach. 

Pages